HCPCS Level II

HCPCS Level II 2007 code changes

Every HCPCS Level II code whose CMS add date or termination date falls in 2007, grouped by effective date. Each code's own page carries its full record.

136

Added

Deleted

For HCPCS Level II, MedCoder records each code's CMS add date and termination date from the alpha-numeric file. A deletion is listed on the first day the code is no longer valid (the day after its CMS termination date). Description revisions between quarterly files are not recorded as changes.

Added effective January 1, 2007 (116)

A4461 — Surgical dressing holder, non-reusable, each
A4463 — Surgical dressing holder, reusable, each
A4559 — Coupling gel or paste, for use with ultrasound device, per oz
A4600 — Sleeve for intermittent limb compression device, replacement only, each
A4601 — Lithium ion battery, rechargeable, for non-prosthetic use, replacement
A8000 — Helmet, protective, soft, prefabricated, includes all components and accessories
A8001 — Helmet, protective, hard, prefabricated, includes all components and accessories
A8002 — Helmet, protective, soft, custom fabricated, includes all components and accessories
A8003 — Helmet, protective, hard, custom fabricated, includes all components and accessories
A8004 — Soft interface for helmet, replacement only
A9279 — Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified
A9527 — Iodine i-125, sodium iodide solution, therapeutic, per millicurie
A9568 — Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries
C1821 — Interspinous process distraction device (implantable)
E0676 — Intermittent limb compression device (includes all accessories), not otherwise specified
E0936 — Continuous passive motion exercise device for use other than knee
E2373 — Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware
E2374 — Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only
E2375 — Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only
E2376 — Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only
E2377 — Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue
E2381 — Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each
E2382 — Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each
E2383 — Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each
E2384 — Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each
E2385 — Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each
E2386 — Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each
E2387 — Power wheelchair accessory, foam filled caster tire, any size, replacement only, each
E2388 — Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each
E2389 — Power wheelchair accessory, foam caster tire, any size, replacement only, each
E2390 — Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each
E2391 — Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each
E2392 — Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each
E2394 — Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each
E2395 — Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each
E2396 — Power wheelchair accessory, caster fork, any size, replacement only, each
G0380 — Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
G0381 — Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
G0382 — Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
G0383 — Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
G0384 — Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
G0389 — Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening
G0390 — Trauma response team associated with hospital critical care service
G9131 — Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
G9132 — Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
G9133 — Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)
G9134 — Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)
G9135 — Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)
G9136 — Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)
G9137 — Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)
G9138 — Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)
G9139 — Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)
H0049 — Alcohol and/or drug screening
H0050 — Alcohol and/or drug services, brief intervention, per 15 minutes
J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0348 — Injection, anidulafungin, 1 mg
J0364 — Injection, apomorphine hydrochloride, 1 mg
J0594 — injection, busulfan, 1 mg
J0894 — Injection, decitabine, 1 mg
J1324 — Injection, enfuvirtide, 1 mg
J1458 — Injection, galsulfase, 1 mg
J1562 — Injection, immune globulin (vivaglobin), 100 mg
J1740 — Injection, ibandronate sodium, 1 mg
J2170 — Injection, mecasermin, 1 mg
J2248 — Injection, micafungin sodium, 1 mg
J2315 — Injection, naltrexone, depot form, 1 mg
J3243 — Injection, tigecycline, 1 mg
J3473 — Injection, hyaluronidase, recombinant, 1 usp unit
J7187 — Injection, von willebrand factor complex (humate-p), per iu vwf:rco
J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
J7615 — Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
J7645 — Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7650 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7660 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7667 — Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
J7670 — Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
J7685 — Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
J8650 — Nabilone, oral, 1 mg
J9261 — Injection, nelarabine, 50 mg
L1001 — Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment
L3806 — Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment
L3808 — Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment
L3915 — Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
L6611 — Addition to upper extremity prosthesis, external powered, additional switch, any type
L6624 — Upper extremity addition, flexion/extension and rotation wrist unit
L6703 — Terminal device, passive hand/mitt, any material, any size
L6704 — Terminal device, sport/recreational/work attachment, any material, any size
L6706 — Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined
L6707 — Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined
L6708 — Terminal device, hand, mechanical, voluntary opening, any material, any size
L6709 — Terminal device, hand, mechanical, voluntary closing, any material, any size
L7007 — Electric hand, switch or myoelectric controlled, adult
L7008 — Electric hand, switch or myoelectric, controlled, pediatric
L7009 — Electric hook, switch or myoelectric controlled, adult
L8690 — Auditory osseointegrated device, includes all internal and external components
L8691 — Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each
L8695 — External recharging system for battery (external) for use with implantable neurostimulator, replacement only
Q4081 — Injection, epoetin alfa, 100 units (for esrd on dialysis)
Q4082 — Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
Q5001 — Hospice or home health care provided in patient's home/residence
Q5002 — Hospice or home health care provided in assisted living facility
Q5003 — Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
Q5004 — Hospice care provided in skilled nursing facility (snf)
Q5005 — Hospice care provided in inpatient hospital
Q5006 — Hospice care provided in inpatient hospice facility
Q5007 — Hospice care provided in long term care facility
Q5008 — Hospice care provided in inpatient psychiatric facility
Q5009 — Hospice or home health care provided in place not otherwise specified (nos)
S3855 — Genetic testing for detection of mutations in the presenilin - 1 gene
T4543 — Adult sized disposable incontinence product, protective brief/diaper, above extra large, each

Added effective April 1, 2007 (6)

S0270 — Physician management of patient home care, standard monthly case rate (per 30 days)
S0271 — Physician management of patient home care, hospice monthly case rate (per 30 days)
S0272 — Physician management of patient home care, episodic care monthly case rate (per 30 days)
S0273 — Physician visit at member's home, outside of a capitation arrangement
S0274 — Nurse practitioner visit at member's home, outside of a capitation arrangement
T1503 — Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit

Added effective July 1, 2007 (13)

C2638 — Brachytherapy source, stranded, iodine-125, per source
C2639 — Brachytherapy source, non-stranded, iodine-125, per source
C2640 — Brachytherapy source, stranded, palladium-103, per source
C2641 — Brachytherapy source, non-stranded, palladium-103, per source
C2642 — Brachytherapy source, stranded, cesium-131, per source
C2643 — Brachytherapy source, non-stranded, cesium-131, per source
C2698 — Brachytherapy source, stranded, not otherwise specified, per source
C2699 — Brachytherapy source, non-stranded, not otherwise specified, per source
C9728 — Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple
S2066 — Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral
S2067 — Breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral
S3800 — Genetic testing for amyotrophic lateral sclerosis (als)
S9152 — Speech therapy, re-evaluation

Added effective October 1, 2007 (1)

G9140 — Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours

Source: CMS HCPCS Level II alpha-numeric file (add and termination dates).

Source data

Source organization: CMS
Source release: HCPCS Level II October 2026 alpha-numeric file
Source file: october-2026-alpha-numeric-hcpcs-file.zip
File checksum (SHA-256): c25240c63108756d4ba6c0ea785c517117d83bfed9526c51da8acf123de1feb6
Data read date: Data not available in the current MedCoder release record.
Effective date: CMS effective dates within 2007
Release type: Quarterly (January, April, July, October), with occasional mid-quarter additions
Methodology: Each code's add date and termination date are read from the alpha-numeric file. A deletion is dated the first day the code is no longer valid, the day after its termination date. Description revisions are not recorded as changes.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

All releases in the Change Ledger